Introduction {#s1}
============

Plant fungal and insect diseases have posed serious threats to crops in the world and caused a severe loss throughout the world (Strange and Scott, [@B9]; Yang et al., [@B22]). Nowadays, some of the available traditional fungicides and insecticides, such as Kresoxim-methyl, Pyrimethanil, Chlorantraniliprole, etc., are widely used to prevent plant harmful fungal and insect diseases. However, prolonged use of traditional pesticides can not only lead to drug resistance, but also have a harmful influence on the safety of the plants and the environment. Therefore, the development of novel and promising fungicides and insecticides is still an urgent task.

Pyrimidine derivatives, which play an important role in synthesis of various active molecules, have versatile properties in modern life, such as antifungal (Chen et al., [@B1]; Zhang et al., [@B23]), antibacterial (Triloknadh et al., [@B10]; Fang et al., [@B3]), insecticidal (Liu et al., [@B5]; Shen et al., [@B7]), herbicidal (Chen et al., [@B2]; Li et al., [@B4]), and antiviral (Xu et al., [@B20]; Wang Y. Y. et al., [@B14]) activities. In the previous work, some of the pyrimidine derivatives (for example, Mepanipyrim, Pyrimethanil, Diflumetorim, Azoxystrobin, and so on), which were known for their abilities to control severe fungal diseases, have been marketed as commercial pesticides worldwide. Meanwhile, in our preliminary work, several series of pyrimidine derivatives containing 1,3,4-oxadiazole ([Figures 1A,E](#F1){ref-type="fig"}), 1,3,4-thiadiazole ([Figures 1B,E](#F1){ref-type="fig"}), 1,2,4-triazole ([Figure 1C](#F1){ref-type="fig"}) or amide ([Figure 1D](#F1){ref-type="fig"}) moiety, as shown in [Figure 1](#F1){ref-type="fig"}, were reported and revealed better antiviral, antifungal, and antibacterial activities (Wu et al., [@B16], [@B17],[@B19], [@B15],[@B18]).

![The structures of the pyrimidine derivatives containing 1,3,4-oxadiazole **(A,E)**, 1,3,4-thiadiazole **(B,E)**, 1,2,4-triazole **(C)** or amide **(D)** moiety reported by our research group.](fchem-08-00522-g0001){#F1}

In recent years, pyridylpyrazole amide derivatives have attracted more and more considerable attention owing to their broad class of biological activities in pesticide chemistry, such as antifungal (Yan et al., [@B21]; Wang B. L. et al., [@B12]) and insecticidal (Wang et al., [@B13], [@B11]; Shi et al., [@B8]; Wang B. L. et al., [@B12]) activity. In the past few years, some representative examples of pyridylpyrazole amide derivatives (for example, chlorantraniliprole and cyantraniliprole) were commercialized as pesticides, as shown in [Figure 2](#F2){ref-type="fig"}.

![Structures of chlorantraniliprole and cyantraniliprole.](fchem-08-00522-g0002){#F2}

To develop effective pesticide agents, we aim to introduce the pyrimidine ring to the pyridiylpyrazol amide skeleton to design a series of novel pyridiylpyrazol amide derivatives containing a pyrimidine moiety ([Figure 3](#F3){ref-type="fig"}). As far as we know, it is the first report on the antifungal and insecticidal activities of pyridylpyrazol amide derivatives containing a pyrimidine moiety.

![Design strategy for title compounds **6a**--**6m**.](fchem-08-00522-g0003){#F3}

Experimental and Methods {#s2}
========================

General Information
-------------------

JEOL-ECX 500 NMR spectrometer (JEOL, Tokyo, Japan) was used to analyse the NMR spectral (^1^H NMR and ^13^C NMR) at room temperature using TMS as an internal standard and DMSO-*d*~6~ as the solvent. Elemental analysis was performed on the Elementar Vario-III CHN analyser (Elementar, Hanau, Germany). Mass spectral were conducted on the Agilent 5973 organic mass spectrometer (Agilent Technologies, Palo Alto, CA, USA). Melting points were determined on the XT-4 binocular microscope (Beijing Tech Instrument Co., China). All commercial reagents and solvents were used as they did not require any purification before use.

Synthesis
---------

### Preparation Procedure of the Key Intermediate 5

The synthetic procedure for the key intermediate **5** is shown in [Scheme 1](#S1){ref-type="fig"}. To a mixture of 2,3-dichloropyridine (0.1 mol) dissolved in anhydrous ethanol (120 mL), 80% hydrazine hydrate (80 mL) was added dropwise and reacted under reflux. Upon completion of the reaction, the reaction solution was cooled to room temperature and the solvent was removed under reduced pressure. The residue was washed with water and recrystallized with ethanol to gain intermediate **1**. Intermediate **1** (90 mmol) and diethyl maleate (90 mmol) were added to the mixture of sodium ethoxide (90 mmol) and ethanol (100 mL), then a moderate amount of glacial acetic acid was added when the temperature was below 60°C. Upon completion of the reaction, the reaction solution was poured into 100 mL distilled water to precipitate the solid, then the solid was recrystallized with ethanol to obtain intermediate **2**. Then, a mixture of intermediate **2** (45 mmol), phosphorus oxychloride (POCl~3~, 50 mmol) or phosphorus oxybromide (POBr~3~, 50 mmol), and acetonitrile (CH~3~CN, 50 mL) was reacted under reflux. After ending the reaction, the reaction mixture was poured into 30 mL distilled water, extracted with dichloromethane (CH~2~Cl~2~), and dried with anhydrous sodium sulfate (Na~2~SO~4~) to give intermediate **3** (Wang B. L. et al., [@B12]). After that, a mixture of intermediate **3** (40 mmol), potassium persulfate (K~2~S~2~O~8~, 44 mmol), and CH~3~CN (50 mL) reacted under reflux. Upon completion of the reaction, the reaction mixture was poured into 100 mL of distilled water. The residue was washed with water and recrystallized with ethanol to obtain intermediate **4** (Wang B. L. et al., [@B12]). Finally, sodium hydroxide (NaOH, 30 mmol) dissolved in 10 mL of water was added to the mixture of intermediate **4** and methanol (20 mL) and reacted under reflux. When the reaction was completed, the reaction mixture was poured into 100 mL of distilled water and acidified the mixture to pH 5--6 using concentrated hydrochloric acid. The key intermediate **5** was attained after recrystallization with ethanol. ^1^H NMR spectral data for intermediates **1--5** are reported in the [Supplementary Data](#SM1){ref-type="supplementary-material"}.

![Synthetic route of the title compounds **6a**--**6m**.](fchem-08-00522-g0004){#S1}

### General Procedure for the Preparation of the Target Compounds 6a−6m

As shown in [Scheme 1](#S1){ref-type="fig"}, oxalyl chloride (2 mL) and 4 drops of *N, N*-dimethylformamide (DMF) were added to a mixture of intermediate **5** dissolved in 10 mL CH~2~Cl~2~, and reacted at room temperature. When the reaction was completed, the CH~2~Cl~2~ and excess oxaloyl chloride were removed under reduced pressure. Then, 5-substituted-4-amino-2-methylpyrimidine was added to the residue dissolved in 5 mL tetrahydrofuran (THF) and reacted under reflux. At the end of the reaction, the reaction mixture was poured into 20 mL of water, extracted with ethyl acetate, and recrystallized with ethanol to obtain the title compounds **6a**--**6m**.

Methyl4-(3-bromo-1-(3-chloropyridin-2-yl)-1*H*-pyrazole-5-carboxamido)-2-methyl-pyrimidine-5-carboxylate (**6a**). White solid; yield 45.1%; m.p. 220--222°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.85 (s, 1H, CONH), 8.84 (s, 1H, Pyrimidine-H), 8.52 (d, 1H, *J* = 4.6 Hz, Pyridine-H), 8.23 (d, 1H, *J* = 6.9 Hz, pyridine-H), 7.67 (dd, 1H, *J*~1~ = 4.55 Hz, *J*~2~ = 8.0 Hz,pyridine-H), 7.58 (s, 1H, Pyrazole-H), 3.61 (s, 3H), 2.62 (s, 3H);^13^C NMR (DMSO-*d*~6~, 125 MHz) δ: 170.51, 165.33, 159.38, 156.62, 154.98, 148.73, 147.82, 140.40, 140.06, 138.27,1 128.50, 127.55, 115.07, 109.32, 52.83, 26.00; MS (ESI) m/z: 451.1 (\[M+H\]^+^); Anal. Calcd. for C~16~H~12~BrClN~6~O~3~: C 42.55, H 2.68, N 18.61; found: C 42.60, H 2.70, N 18.66.

Ethyl4-(3-bromo-1-(3-chloropyridin-2-yl)-1*H*-pyrazole-5-carboxamido)-2-methyl-pyrimidine-5-carboxylate (**6b**). White crystals; yield 50.4%; m.p. 176--177°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.88 (s, 1H, CONH), 8.84 (s, 1H, Pyrimidine-H), 8.51 (d, 1H, *J* = 4.0 Hz, Pyridine-H), 8.24 (d, 1H, *J* = 8.0 Hz, pyridine-H), 7.66 (dd, 1H, *J*~1~ = 4.55 Hz, *J*~2~ = 8.0 Hz, pyridine-H), 7.59 (s, 1H, Pyrazole-H), 4.09 (q, 2H, *J* = 6.9 Hz), 2.64 (s, 3H), 1.08 (t, 3H, *J* = 7.45 Hz); ^13^C NMR (DMSO-*d*~6~, 125 MHz) δ: 170.51, 164.80, 159.38, 156.64, 148.73, 147.80, 140.33, 140.07, 138.27, 128.46, 127.52, 115.38, 109.34, 61.68, 25.97, 14.32; MS (ESI) m/z: 465.1 (\[M+H\]^+^); Anal. Calcd. for C~17~H~14~BrClN~6~O~3~: C 43.85, H 3.03, N 18.05; found: C 43.90, H 3.00, N 18.06.

Methyl4-(3-chloro-1-(3-chloropyridin-2-yl)-1*H*-pyrazole-5-carboxamido)-2-methyl-pyrimidine-5-carboxylate (**6c**). White solid; yield 48.2%; m.p. 213--215°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.87 (s, 1H, CONH), 8.85 (s, 1H, Pyrimidine-H), 8.53 (d, 1H, *J* = 2.85 Hz, Pyridine-H), 8.25 (d, 1H, *J* = 7.65 Hz, pyridine-H), 7.68 (dd, 1H, *J*~1~ = 2.85 Hz, *J*~2~ = 8.0 Hz, pyridine-H), 7.55 (s, 1H, Pyrazole-H), 3.62 (s, 3H), 2.64 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 125 MHz) δ: 170.54, 165.32, 159.41, 156.62, 155.01, 148.71, 147.85, 140.48, 140.01, 138.30, 128.51, 127.54, 115.05, 109.30, 52.82, 26.01; MS (ESI) m/z: 407.1 (\[M+H\]^+^); Anal. Calcd. for C~16~H~12~Cl~2~N~6~O~3~: C 47.19, H 2.97, N 20.64; found: C 47.20, H 3.00, N 20.62.

Ethyl4-(3-chloro-1-(3-chloropyridin-2-yl)-1*H*-pyrazole-5-carboxamido)-2-methyl-pyrimidine-5-carboxylate (**6d**). Yellow crystals; yield 38.5%; m.p. 191--192°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.88 (s, 1H, CONH), 8.84 (s, 1H, Pyrimidine-H), 8.51 (d, 1H, *J* = 2.85Hz, Pyridine-H), 8.23 (d, 1H, *J* = 7.65 Hz, pyridine-H), 7.66 (dd, 1H, *J*~1~ = 2.85 Hz, *J*~2~ = 8.00 Hz, pyridine-H), 7.53 (s, 1H, Pyrazole-H), 4.06 (q, 2H, *J* = 6.90 Hz), 2.64 (s, 3H), 1.08 (t, 3H, *J* = 6.85 Hz); ^13^C NMR (DMSO-*d*~6~, 125 MHz) δ: 170.52, 164.80, 159.38, 156.64, 148.73, 147.80, 140.33, 140.07, 138.27, 128.46, 127.52, 115.38, 109.34,61.68, 25.97,14.32; MS (ESI) m/z: 422.1 (\[M+H\]^+^); Anal. Calcd. for C~17~H~14~Cl~2~N~6~O~3~: C 48.47, H 3.35, N 19.95; found: C 48.50, H 3.40, N 20.02.

4-(3-Bromo-1-(3-chloropyridin-2-yl)-1*H*-pyrazole-5-carboxamido)-*N*-2-dimethylpyrimidine-5-carboxamide (**6e**). White solid; yield 52.6%; m.p. 228--233°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 12.33 (s, 1H, CONH), 8.78 (s, 1H, Pyrimidine-H), 8.74 (d, 1H, *J* = 4.55 Hz, CONH), 8.48 (d, 1H, *J* = 4.00 Hz, Pyridine-H), 8.19 (d, 1H, *J* = 8.05Hz, Pyridine-H), 7.62 (dd, 1H, *J*~1~ = 4.60 Hz, *J*~2~ = 8.00 Hz, Pyridine-H), 7.32 (s, 1H, Pyrazole-H), 2.67 (d, 3H, *J* = 4.6 Hz), 2.45 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 125 MHz)δ: 169.38, 165.98, 157.28, 156.02, 154.80, 148.58, 147.82, 140.09, 139.38, 128.40, 127.68, 127.48, 114.27, 111.72, 26.67, 26.07; MS (ESI) m/z: 450.1 (\[M+H\]^+^); Anal. Calcd. for C~16~H~13~BrClN~7~O~2~: C 42.64, H 2.91, N 21.76; found: C 42.66, H 2.90, N 21.77.

4-(3-Bromo-1-(3-chloropyridin-2-yl)-1*H*-pyrazole-5-carboxamido)-*N*-ethyl-2-methylpyrimidine-5-carboxamide (**6f**). White solid; yield 60.1%; m.p. 236--237°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 12.33 (s, 1H, CONH), 8.78 (s, 1H, Pyrimidine-H), 8.72 (s, 1H, CONH), 8.48 (d, 1H, *J* = 4.00 Hz, Pyridine-H), 8.19 (d, 1H, *J* = 8.05 Hz, Pyridine-H), 7.62 (dd, 1H, *J*~1~ = 4.60 Hz, *J*~2~ = 8.00 Hz, Pyridine-H), 7.32 (s, 1H, Pyrazole-H), 2.84 (q, 2H, *J* = 6.85 Hz), 2.45 (s, 3H), 1.04 (t, 3H, *J* = 6.25 Hz); ^13^C NMR (DMSO-*d*~6~, 125 MHz)δ: 169.35, 166.00, 157.31, 156.04, 154.78, 148.60, 147.81, 140.11, 139.35, 128.42, 127.65, 127.49, 114.27, 111.76, 26.66, 26.03, 15.32; MS (ESI) m/z: 464.1 (\[M+H\]^+^); Anal. Calcd. for C~17~H~15~BrClN~7~O~2~: C 42.64, H 2.91, N 21.76; found: C 42.66, H 2.90, N 21.77.

4-(3-Chloro-1-(3-chloropyridin-2-yl)-1*H*-pyrazole-5-carboxamido)-*N*,2-dimethylpyrimidine-5-carboxamide (**6g**). White solid; yield 45.9%; m.p. 213--215°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.87 (s, 1H, CONH), 8.85 (s, 1H, Pyrimidine-H), 8.71 (s, 1H, CONH), 8.53 (d, 1H, *J*= 2.85 Hz, Pyridine-H), 8.25 (d, 1H, *J* = 7.65 Hz, Pyridine-H), 7.68 (dd, 1H, *J*~1~ = 2.85 Hz, *J*~2~ = 8.0 Hz, Pyridine-H), 7.55 (s, 1H, Pyrazole-H), 2.85 (s, 3H), 2.64 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 125 MHz) δ: 170.51, 165.33, 159.38, 156.62, 154.98, 148.73, 147.82, 140.40, 140.06, 138.27, 128.50, 127.55, 115.07, 109.32, 52.83, 26.62, 26.04; MS (ESI) m/z: 406.1 (\[M+H\]^+^); Anal. Calcd. for C~16~H~13~Cl~2~N~7~O~2~: C 47.31, H 3.23, N 24.14; found: C 47.32, H 3.20, N 24.12.

4-(3-Chloro-1-(3-chloropyridin-2-yl)-1*H*-pyrazole-5-carboxamido)-*N*-ethyl-2-methylpyrimidine-5-carboxamide (**6h**). Yellow crystals; yield 47.8%; m.p. 191--192°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.88 (s, 1H, CONH), 8.84 (s, 1H, Pyrimidine-H), 8.71 (s, 1H, CONH), 8.51 (d, 1H, *J* = 2.85 Hz, Pyridine-H), 8.23 (d, 1H, *J* = 7.65 Hz, pyridine-H), 7.66 (dd, 1H, *J*~1~ = 2.85 Hz, *J*~2~ = 8.00 Hz, pyridine-H), 7.53 (s, 1H, Pyrazole-H), 4.06 (q, 2H, *J* = 6.90 Hz), 2.64 (s, 3H), 1.08 (t, 3H, *J* = 6.85 Hz); ^13^C NMR (DMSO-*d*~6~, 125 MHz) δ: 170.52, 164.89, 159.38, 156.64, 148.73, 147.80, 140.33, 140.07, 138.27, 128.46, 127.52, 115.38, 109.34, 61.68, 25.97,15.32; MS (ESI) m/z: 420.1 (\[M+H\]^+^); Anal. Calcd. for C~17~H~15~Cl~2~N~7~O~2~: C 48.59, H 3.60, N 23.33; found: C 48.61, H 3.62, N 23.30.

3-Bromo-1-(3-chloropyridin-2-yl)-*N*-(2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyrimidin-4-yl)-1*H*-pyrazole-5-carboxamide (**6i**). Yellow crystals; yield 36.5%; m.p. 180--181°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.64 (s, 1H, CONH), 8.99 (s, 1H, Pyrimidine-H), 8.49 (d, 1H, *J* = 4.55 Hz, Pyridine-H), 8.18 (d, 1H, *J* = 8.05 Hz, Pyridine-H), 7.63 (dd, 1H, *J*~1~ = 4.60 Hz, *J*~2~ = 8.0 Hz, Pyridine-H), 7.54 (s, 1H, Pyrazole-H), 2.67 (s, 3H), 2.61 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 125 MHz)δ: 177.49, 169.89, 164.89, 158.92, 155.80, 155.08, 148.68, 147.69, 139.94, 138.68, 128.48, 127.52, 127.41, 112.34, 111.50, 25.96, 12.43; MS (ESI) m/z: 475.1 (\[M+H\]^+^); Anal. Calcd. for C~17~H~12~BrClN~8~O~2~: C 42.92, H 2.54, N 23.56; found: C 42.91, H 2.50, N 23.60.

3-Chloro-1-(3-chloropyridin-2-yl)-*N*-(2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)pyrimidin-4-yl)-1*H*-pyrazole-5-carboxamide (**6j**). Yellow crystals; yield 41.3%; m.p. 151--152°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.64 (s, 1H, CONH), 8.99 (s, 1H, Pyrimidine-H), 8.49 (d, 1H, *J* = 4.55 Hz, Pyridine-H), 8.18 (d, 1H, *J* = 8.05 Hz, Pyridine-H), 7.63 (dd, 1H, *J*~1~ = 4.60 Hz, *J*~2~ = 8.0 Hz, Pyridine-H), 7.54 (s, 1H, Pyrazole-H), 2.67 (s, 3H), 2.61 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 125 MHz)δ: 177.52, 169.87, 164.92, 158.94, 155.85, 155.11, 148.65, 147.72, 139.99, 138.71, 128.50, 127.53, 127.45, 112.36, 111.32, 26.02, 12.45; MS (ESI) m/z: 431.1 (\[M+H\]^+^); Anal. Calcd. for C~17~H~12~BrClN~8~O~2~: C 47.35, H 2.80, N 25.98; found: 47.37, H 2.77, N 25.99.

3-Bromo-1-(3-chloropyridin-2-yl)-*N*-(2-methyl-5-(5-(methylthio)-1,3,4-oxadiazol-2-yl)pyrimidin-4-yl)-1*H*-pyrazole-5-carboxamide (**6k**). Yellow crystals; yield 46.8%; m.p. 166--168°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.84 (s, 1H, CONH), 9.04 (s, 1H, Pyrimidine-H), 8.46 (d, 1H, *J* = 5.15 Hz, Pyridine-H), 8.18 (d, 1H, *J* = 8.0 Hz, Pyridine-H), 7.62 (dd, 1H, *J*~1~ = 4.55 Hz, *J*~2~ = 7.7 Hz, Pyridine-H), 7.58 (s, 1H, Pyrazole-H), 2.72 (s, 3H), 2.66 (s, 3H); ^13^C NMR (DMSO-*d*~6~, 125 MHz) δ: 170.30, 164.72, 162.00, 158.79, 156.05, 148.51, 148.10, 147.81, 140.01, 138.54, 128.35, 127.60, 127.42, 112.61, 108.46, 26.10, 15.62; MS (ESI) m/z: 507.1 (\[M+H\]^+^); Anal. Calcd. for C~17~H~12~BrClN~8~O~2~S: C 40.21, H 2.38, N22.07; found: C 40.24, H 2.40, N22.05.

3-Bromo-1-(3-chloropyridin-2-yl)-*N*-(5-(5-(ethylthio)-1,3,4-oxadiazol-2-yl)-2-methylpyrimidin-4-yl)-1*H*-pyrazole-5-carboxamide (**6l**). Yellow crystals; yield 42.5%; m.p. 176--177°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.84 (s, 1H, CONH), 9.04 (s, 1H, Pyrimidine-H), 8.46 (d, 1H, *J* = 5.15 Hz, Pyridine-H), 8.18 (d, 1H, *J* = 8.0 Hz, Pyridine-H), 7.62 (dd, 1H, *J*~1~ = 4.55 Hz, *J*~2~ = 7.7 Hz, Pyridine-H), 7.58 (s, 1H, Pyrazole-H), 3.12 (q, 2H, *J* = 6.9 Hz), 2.66 (s, 3H), 1.35 (t, 3H, *J* = 7.45 Hz); ^13^C NMR (DMSO-*d*~6~, 125 MHz) δ: 170.25, 164.74, 161.95, 158.75, 156.08, 148.25, 148.12, 147.69, 140.07, 138.55, 128.27, 127.60, 127.44, 112.63, 108.56, 27.86, 26.10, 14.23; MS (ESI) m/z: 521.1 (\[M+H\]^+^); Anal. Calcd. for C~18~H~14~BrClN~8~O~2~S: C 41.43, H 2.70, N 21.48; found: C 41.45, H 2.74, N 21.49.

3-Bromo-1-(3-chloropyridin-2-yl)-N-(2-methyl-5-(5-(propylthio)-1,3,4-oxadiazol-2-yl)pyrimidin-4-yl)-1*H*-pyrazole-5-carboxamide (**6m**). Yellow crystals; yield 39.8%; m.p. 197--199°C; ^1^H NMR (DMSO-*d*~6~, 500 MHz) δ: 11.84 (s, 1H, CONH), 9.04 (s, 1H, Pyrimidine-H), 8.46 (d, 1H, *J*=5.15 Hz, Pyridine-H), 8.18 (d, 1H, *J* = 8.0 Hz, Pyridine-H), 7.62 (dd, 1H, *J*~1~ = 4.55 Hz, *J*~2~ = 7.7 Hz, Pyridine-H), 7.58 (s, 1H, Pyrazole-H), 3.15 (t, 2H, *J* = 6.9 Hz), 2.66 (s, 3H), 1.68 (m, 2H), 0.95 (t, 3H, *J* = 7.45 Hz); ^13^C NMR (DMSO-*d*~6~, 125 MHz)δ: 170.31, 164.70, 162.03, 158.75, 156.02, 148.48, 148.07, 147.77, 140.04, 138.50, 128.32, 127.60, 127.44, 112.67, 108.49, 34.43, 26.10, 22.92, 13.33; MS (ESI) m/z: 535.1 (\[M+H\]^+^); Anal. Calcd. for C~19~H~16~BrClN~8~O~2~S: C 42.59, H 3.01, N 20.91; found: C 42.53, H 3.00, N 20.92.

### Antifungal Biological Assay

The antifungal activities of the title compounds **6a**--**6m** against *Sclerotinia sclerotiorum* (*S. sclerotiorum*), *Phytophthora infestans* (*P. infestans*), *Thanatephorus cucumeris* (*T. cucumeris*), *Gibberella zeae* (*G. zeae*), *Fusarium oxysporum* (*F. oxysporum*), *Cytospora mandshurica* (*C. mandshurica*), *Botryosphaeria dothidea* (*B. dothidea*), and *Phompsis* sp. were evaluated at the concentration of 50 μg/mL (Min et al., [@B6]; Wu et al., [@B15],[@B18]). The target compounds **6a**--**6m** (5 mg) were dissolved in dimethyl sulfoxide (1 mL) and sterile water (9 mL) before mixing with 90 mL potato dextrose agar (PDA) to generate a final concentration of 50 μg/mL. Then, 4 mm diameter of the mycelia dishes were cut from a culture medium of pathogenic fungi, then inoculated in the middle of PDA and cultivated at 27 ± 1°C for 4--5 days. DMSO in sterile distilled water served as a negative control, while Kresoxim-methyl and Pyrimethanil acted as positive controls. For each treatment, three replicates were conducted. The radial growth of the fungal colonies was measured and the data were statistically analyzed. The inhibition rate *I* (%) of the test compounds against eight pathogenic fungi were calculated by the following formula, where *C* represents the diameter of fungi growth on untreated PDA, and *T* represents the diameter of fungi on treated PDA.
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### Insecticidal Biological Assay

The insecticidal activities of all synthesized compounds **6a**--**6m** against *Spodoptera litura* (*S. litura*), *Mythimna separata* (*M. separata*)*, Pyrausta nubilalis* (*P. nubilalis*)*, Tetranychus urticae* (*T. urticae*)*, Rhopalosiphum maidis* (*R. maidis*), and *Nilaparvata lugens* (*N. lugens*) were performed according to the reported method (Wang B. L. et al., [@B12]; Wang et al., [@B11]). The target compounds **6a**--**6m** were dissolved in NP-10 (0.1 mg/L) solution to generate a final concentration of 200 μg/mL. Then, 15 maize leaves (approximately 5 cm in length) and 5 sweet potato leaves (diameter 3 cm) were dipped in the test compounds solutions for 10 s, dried and placed into a tumbler. After that, 30 larvae of second-instar *S. litura, M. separata, P. nubilalis, T. urticae, R. maidis*, and *N. lugens* were transferred to the petri dish. Chlorantraniliprole was used as a control. All bioassays were performed in the laboratory at 27 ± 1°C for 48 h. Three replicates were performed for each treatment. The percentage of mortalities for the target compounds were determined using Abbott\'s formula.

Results and Discussion {#s3}
======================

In this study, using 2,3-dichloropyridine as the starting material, the title compounds **6a**--**6m** were synthesized in six steps, including hydrazidation, cyclization, bromination or chlorination, oxidation, hydrolyzation, and condensation. The target compounds structures were confirmed by ^1^H NMR, ^13^C NMR, MS, and elemental analysis. In the ^1^H NMR spectra of compound **6a**, a singlet at 2.45 ppm assigned to CH~3~ protons of pyrimidine-CH~3~, the doublet signal at 2.67 ppm indicated the presence of CH~3~ proton in CONH-CH~3~, meanwhile, a singlet at 8.78 and 7.32 ppm indicated the presence of pyrimidine and pyrazole ring. Two proton signals of two -CONH- in amide moiety was observed at 12.33 and 8.74 ppm. The structure of **6b** was also confirmed by its mass spectral data. In its mass spectrum, the molecular ion peak was noticed m/z at 450.1 (\[M+H\]^+^) corresponding to its molecular weight.

The *in vitro* antifungal activities at 50 μg/mL of the target compounds against eight plant fungi are listed in [Table 1](#T1){ref-type="table"}. [Table 1](#T1){ref-type="table"} showed that, at 50 μg/mL, compounds **6a**--**6m** indicated certain antifungal activities against *S. sclerotiorum, P. infestans, T. cucumeris, G. zeae, F. oxysporum, C. mandshurica, B. dothidea*, and *Phompsis* sp. with the inhibition rates of 6.5--54.1%, 8.7--48.6%, 3.2--54.7%, 0--54.9%, 0--66.3%, 10.7--49.4%, 30.1--85.9%, and 36.2--81.2%, respectively. Among the title compounds, compound **6i** revealed good *in vitro* antifungal activities against *P. infestans* and *B. dothidea*, with the inhibition rates of 48.6% and 85.9%, respectively, which were equally to those of Kresoxim-methyl or Pyrimethanil. Meanwhile, compound **6j** revealed good *in vitro* antifungal activities against *S. sclerotiorum, G. zeae, C. mandshurica*, and *B. dothidea*, with the inhibition rates of 54.1, 54.9, 49.4, and 85.9%, respectively, which were similar with those of Kresoxim-methyl or Pyrimethanil.

###### 

The *in vitro* antifungal activity of the title compounds 6a--6m at 50 μg/mL.

  **Compds**.       **Inhibition rate (%)**                                                                                 
  ----------------- ------------------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
  **6a**            27.5 ± 1.1                20.7 ± 1.0   6.8 ± 1.9    0            16.9 ± 0.9   10.7 ± 1.1   31.6 ± 2.1   36.2 ± 1.4
  **6b**            37.8 ± 1.6                29.6 ± 1.3   19.7 ± 1.4   8.7 ± 1.1    36.0 ± 1.3   40.2 ± 1.7   36.5 ± 1.6   42.1 ± 1.0
  **6c**            35.0 ± 1.4                16.8 ± 1.3   14.2 ± 0.9   34.2 ± 1.3   12.1 ± 0.9   22.2 ± 1.0   45.9 ± 3.3   53.5 ± 1.2
  **6d**            34.0 ± 1.3                8.7 ± 0.8    8.1 ± 1.2    0            2.6 ± 1.1    11.7 ± 0.9   50.8 ± 3.1   57.5 ± 2.1
  **6e**            6.5 ± 0.9                 10.0 ± 0.9   3.2 ± 1.0    9.9 ± 0.9    0            12.8 ± 3.0   30.1 ± 1.9   40.3 ± 2.7
  **6f**            11.8 ± 3.8                15.1 ± 1.2   9.4 ± 1.2    7.8 ± 2.2    16.2 ± 1.7   21.2 ± 0.9   37.5 ± 3.0   46.2 ± 1.4
  **6g**            41.5 ± 1.0                32.9 ± 1.0   35.2 ± 1.3   15.1 ± 1.5   32.1 ± 0.9   14.8 ± 0.9   38.4 ± 1.2   41.8 ± 3.3
  **6h**            37.4 ± 1.2                27.0 ± 0.9   37.5 ± 1.0   21.6 ± 1.5   25.3 ± 1.9   20.7 ± 1.0   44.9 ± 3.0   46.3 ± 2.2
  **6i**            47.9 ± 1.6                48.6 ± 1.4   49.2 ± 1.8   48.8 ± 1.6   66.3 ± 1.0   41.5 ± 1.4   85.9 ± 1.1   81.2 ± 2.4
  **6j**            54.1 ± 1.1                42.5 ± 1.2   54.7 ± 2.3   54.9 ± 1.5   53.8 ± 1.3   49.4 ± 1.2   83.6 ± 2.1   78.8 ± 1.2
  **6k**            39.9 ± 3.1                30.1 ± 0.9   47.9 ± 1.2   41.2 ± 1.1   45.6 ± 1.1   47.7 ± 1.3   55.6 ± 2.8   57.0 ± 1.9
  **6l**            30.6 ± 2.3                24.1 ± 1.7   40.3 ± 2.6   33.7 ± 2.8   38.5 ± 2.3   40.2 ± 1.8   59.5 ± 3.0   62.2 ± 3.5
  **6m**            24.8 ± 1.2                16.3 ± 1.4   34.6 ± 0.9   24.9 ± 1.7   32.2 ± 1.6   32.5 ± 1.6   46.2 ± 2.7   51.4 ± 2.0
  Kresoxim-methyl   52.3 ± 1.1                49.8 ± 1.0   64.1 ± 1.2   56.9 ± 1.0   70.6 ± 1.2   51.1 ± 1.3   /            /
  Pyrimethanil      /                         /            /            /            /            /            84.4 ± 2.1   85.1 ± 1.4

Based on the preliminary antifungal bioassays, the EC~50~ values of compounds **6i** and **6j** were also tested and presented in [Table 2](#T2){ref-type="table"}. [Table 2](#T2){ref-type="table"} showed that compounds **6i** and **6j** showed good activities against *B. dothidea*, with EC~50~ values of 56.4 and 65.3 μg/mL, respectively, which were similar to that of Pyrimethanil (57.6 μg/mL).

###### 

The EC~50~ values of compounds 6i and 6j against *B. dothidea*.

  **Compounds**   **Toxic regression equation**   ***r***   **EC~**50**~ (μg/mL)**
  --------------- ------------------------------- --------- ------------------------
  **6i**          y = 1.21 × +3.56                0.99      56.4 ± 1.2
  **6j**          y = 0.85x + 4.15                0.99      65.3 ± 1.1
  Pyrimethanil    y = 1.01x + 6.25                0.99      57.6 ± 1.8

The *in vitro* insecticidal properties of title compounds against *S. litura, M. separata, P. nubilalis, T. urticae, R. maidis*, and *N. lugens* were evaluated and the insecticidal bioassay results are listed in [Table 3](#T3){ref-type="table"}. [Table 3](#T3){ref-type="table"} showed that the target compounds **6a**--**6m** indicated certain insecticidal activities against *S. litura, M. separata, P. nubilalis, T. urticae, R. maidis*, and *N. lugens* at 200 μg/mL, with the mortality rates of 10.0--70.2%, 12.0--75.4%, 0--61.3%, 43.0--80.9%, 20.0--88.9%, and 11.0--78.6%, respectively, which were lower than those of Chlorantraniliprole. Especially, compound **6f** revealed good insecticidal activities against *S. litura, M. separata, P. nubilalis, T. urticae*, and *N. lugens* with mortality rates of 70.2, 75.4, 61.3, 80.9, and 78.6%, respectively. Meanwhile, compound **6c** had a good mortality rate of 88.9% against *R. maidis*.

###### 

The insecticidal activities of the title compounds 6a--6m at 200 μg/mL.

  **Compds**.           **Mortality rate (%)**                                                       
  --------------------- ------------------------ ------------ ------------ ------------ ------------ ------------
  **6a**                21.8 ± 1.2               12.0 ± 2.5   25.6 ± 2.0   49.8 ± 0.9   20.0 ± 1.8   64.1 ± 2.6
  **6b**                10.0 ± 1.0               48.5 ± 3.2   31.6 ± 1.5   59.6 ± 2.2   30.0 ± 2.2   74.6 ± 3.0
  **6c**                11.8 ± 1.5               56.8 ± 2.8   28.1 ± 1.2   43.0 ± 2.6   88.9 ± 2.0   67.3 ± 2.8
  **6d**                18.6 ± 2.0               16.7 ± 2.2   0            57.2 ± 2.5   22.4 ± 1.1   63.5 ± 2.5
  **6e**                43.3 ± 2.5               66.3 ± 2.0   42.7 ± 2.3   51.6 ± 2.0   26.7 ± 1.5   50.3 ± 1.5
  **6f**                70.2 ± 2.8               75.4 ± 2.8   61.3 ± 4.5   80.9 ± 4.5   65.5 ± 3.0   78.6 ± 3.3
  **6g**                45.2 ± 2.0               19.6 ± 1.0   38.3 ± 1.1   57.2 ± 3.5   40.9 ± 2.0   41.6 ± 2.5
  **6h**                37.5 ± 2.2               24.8 ± 1.5   46.9 ± 3.2   61.4 ± 2.8   36.5 ± 1.5   50.5 ± 3.1
  **6i**                30.0 ± 1.8               26.6 ± 2.0   10.0 ± 2.2   52.7 ± 2.5   37.8 ± 1.2   28.4 ± 1.8
  **6j**                35.3 ± 1.5               31.2 ± 2.8   26.1 ± 1.8   61.7 ± 3.0   43.2 ± 1.8   24.1 ± 1.5
  **6k**                40.2 ± 1.4               32.0 ± 2.1   18.4 ± 1.5   72.6 ± 2.6   40.2 ± 1.5   32.5 ± 2.8
  **6l**                32.4 ± 1.0               27.5 ± 1.5   23.5 ± 1.5   64.5 ± 2.2   33.8 ± 1.0   23.8 ± 1.9
  **6m**                26.1 ± 0.8               23.4 ± 1.2   28.2 ± 1.0   57.8 ± 2.0   26.6 ± 0.8   11.0 ± 2.5
  Chlorantraniliprole   100.0                    100.0        100.0        100.0        100.0        100.0

Conclusions {#s4}
===========

In summary, thirteen novel pyridylpyrazolamide derivatives containing pyrimidine motifs were synthesized, and their structures confirmed by ^1^H NMR, ^13^C NMR, MS and elemental analysis. Bioassay results showed that some of title compounds revealed good antifungal and insecticidal properties. The results provided strategy for leading the synthesis of novel pyridylpyrazolamide derivatives containing pyrimidine motifs.
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